Universal vaccine needed to prevent future COVID-19 waves, study suggests
A model of COVID-19 dynamics in South Africa reveals epidemiological characteristics of the main SARS-CoV-2 variants of concern and highlights their potential to cause further outbreaks.
Sexual Dysfunction, Hair Loss Linked With Long COVID
Hair loss, reduced sex drive, and erectile dysfunction have joined a list of better-known symptoms linked to long COVID in patients who were not hospitalized, according to findings of a large study.
Report on Weekly Deaths in South Africa
South Africa weekly deaths from all causes: 29 Dec 2019 – 6 Aug 2022
Ghana: Importance of Full Vaccination Against COVID-19
Ghana's policy is to create herd immunity by vaccinating at least 20 million out of the current estimated 30.8 million Ghanaians and the first-ever COVID-19 vaccination in the country begun on Tuesday, March 2, 2021, as a measure to curb the further spread of the disease.
What Omicron’s BA.4 and BA.5 variants mean for the pandemic
The lineages’ rise seems to stem from their ability to infect people who were immune to earlier forms of Omicron and other variants.
New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative
Report fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged
A ‘landmark' trial to test mRNA vaccines against COVID-19 in Africa can't get the coveted shots
Pfizer declined to participate in a study involving HIV-infected people and pregnant women and Moderna is balking
Science in Africa: lessons from the COVID-19 pandemic
The continent followed Western nations too closely in its early response to the coronavirus emergency, says Nigerian virologist Oyewale Tomori.
Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech (SVA.O) to target the Omnicom variant were approved for clinical trials in Hong Kong
Britain gives first European approval to Valneva COVID shot
Britain approved Valneva's COVID-19 vaccine on Thursday, becoming the first European country to clear the use of the French firm's shot